µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º faMUd#o&
XP{ nf9&
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ ;7 IVg[f
EH,uX{`e
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) J^t=.-a|
c/g(=F__[
1. ICAM-1 S3 x:]E:
_@"Y3L
qi
2. interleukin 12(IL-12) Z;%qpsq
~t#'X8.)
3. tumor infiltrating lymphocyte V8,$<1Fi;-
RmzK?muk
4. TCR/CD3 complex 5dL-v&W
]B5\S
5. hematopoietin receptor family kxf'_Nzy
E6@+w. VVO
6. individual idiotype(IdI) N%Lh_2EzqV
(tVY
/(~#
7. integrin [n< U>up
xt3IR0
8. colony-stimulatory factor (CSF) $*2uI?87}:
Ebq5P$
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© OZISh?
g@1MImc'!
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? 9Y/c<gbY
sL!6-[N
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ 1p{\jCi,2
<:%Iq13D
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ!\!fd(BN
@AyC0}
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ vn
kktD'n
=-vk}O0C
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) #s]]\
NIYAcLa@n8
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ <89js87
=Qz8"rt#
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) 0TVO'$Gvi
bu$5gGWVf
3. immunoglobulin superfamily (IgSF) i5)trSM|
!>2s5^JI9
4. selectin 1`h`-dqr#
"b} ^xy
5. anti-idiotypic antibody (¦ÁId) hL8QA!
Nzr zLK
6. major histocompatibility complex(MHC) os#j;C]l
?EYF61?
rw
7. immunotolerance u2!8'-Ai
Nf$Y
-v?i
8. biological reponse modifier(BRM) ;((gmg7,
43 |zjE
9. immune reponse gene (Ir gene) Kj'm<]u
e[{LNM{/#
10. reshaped antibody (or reconstituted antibody) J .El&Dev
hDz_BvE
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© _c%~\LOk
y0rT=kU
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ ;9;.!4g/T
E!ZDqq
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? ;r`[6[AG
nY(jN D
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ OlV>zam
TmO\!`
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? Z1q'4h=F.
E9
q8tE}
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ lOZ.{0{f,
9]hc{\
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? ,`H=%#
N}s[0s
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ M*0&3Y
Z
^hZwm8G
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ Tk+\Biq
7E|0'PPR
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? (|bht 0
o#w6]Fmc
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 6G1Z"9<2*
B?TA
S
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: l`,`N+FG
O|av(F9
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: x6F\|nb
HlV3rYh
̉񧄤 VX;u54hS
o@;w!'
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© V+D "_
H&%=>hyX
1. CD8 TcRnjsY$
~|!q>z
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) c~c3;
/:%^Vh3XF
3. immunoglobulin fold(Ig fold) R %}k52`
hvpn=0@M
4. cadherin (Ca-dependent cell adhesion moleculers) P.[>x
MTqbQ69v
5. idiotype-anti-idiotypic antibody immune network theory c&R .
|y=CmNG,
6. HLA class II antigen vTB*J,6.
-j<UhW
7. complementarity-determining region (CDR) \HH|{
J qU%$[w
8. perforin(or pore-forming protein ,PFP) .h*&$c/l
=z@'vu$Fh
9. high affinity IL-2 receptor Jl^oDW
j^64 :3
10. artificial active immunization _$Fi]l!f
o}Xp-P
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© =%RDT9T.
zV2c`he%z
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠFyY;F;4P
wOa_"
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 6
a$%
cBm3|@7
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ |E?%Cj^W
Mz"kaO
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ W C`1;(#G
j5
ui
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ :A
1,3g
_wX'u,HrC
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? I
#A`fJ
b,K1EEJ
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ O &X-)g=
&7<~Q\XZbI
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ "Dy&`
wr#+q1v
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ :Mt/6}
?9PNCd3$d
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ oYqC"g&4Z
}Rf }
iG
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© s ^}V
Rdv"Aj:
1. immunoglobulin gene rearrangement 4H " *.l
XBeHyQp
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) |0Zj/1<$
R'80 {
3. flow cytometry(FCM) H?B.Hp|
A&t}s
#3
4. carrier effect {`}RYfZ
?s
_q|d_
5. positive selection of T lymphocytes in thymus koi
e
.II'W3Fr
6. mouse TH1(Th1) and TH2(Th2) subsets 2s(K4~e e
#:{u1sq;
7. perforin (pore-forming protein ,PFP) LXx3
8>epKFEg
8. ADCC(antibody-dependent cell-mediated cytotoxicity) D)!k
2xjS;lpw
9. SH-2(src-homology region 2) `bx gg'V
:`uo]B"
10. Ab2¦Â (internal image) >uUbWKn3
f^]2qoN
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© yC _X@o-n
*F9uv)[kz
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹?
k/t4
$U6)km4
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? +-{HT+W
t[DXG2&
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ=6%0pu]0
\dCdyl6V
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ +^%F8GB
uH7u4f1Q
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠCx@, J\rsQ
%RJW@~!
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) ~+|p.(I
Sx pl%
ÃâÒßѧרҵ£º 3<'n>'
uL1
-@D,
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ rv\<Q-uQ8
le1'r>E$
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? gsZCWT
=*I>MgCJ
´«È¾²¡Ñ§×¨Òµ£º 0lW}l9}'-
V%3K")
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ ni3^J5X W
o05) I2
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ 7?F0~[eGG
44cyD _(
Ïû»¯×¨Òµ£º 92S<TAdPP
xr o
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ F|Ou5WD
F9Mv$g79
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? sl`\g1<{`
!K3
#4
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ ;K`qSX;;c(
MQLa+I,S4
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© (L
q^C=
02b v0
1. Fas(CD95)/FasL R5|c4v{B
z0doLb^!
2. common chain of cytokine receptor }oloMtp
$
\V}?K0#bt
3 . TCR/CD3 complex PT|t6V"wd
Pij*?qmeQ
4. negaive selection of thymocytes U^:+J-z{
D1#fy=u69|
5. artificial active immune vz/.*u
^jq QG+`?
6. anti-idiotypic qfx=
]qvrpI!E!
7. IgSF \"|E8A6/
c|IH|y
8. Integrin gT?:zd=;
e@w-4G(;
9. chemokine 2E;UHR
Hq ]f$Q6:
10. B7/CD28 MZl6J
^FIpkhw
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© [x{'NwP?
MV'q_{J
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ *@^9]$*$
:G!i]1x<
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ 8{^zXJi]m
~M _@_
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ `O/1aW1
PFq1Zai}n|
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ qT5q3 A(8
k[#<=G_=/E
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ lkl+o&D9
n
W:P"L
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ "MM)AY*b
(#KSwWo{ed
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© z_nv|5"
y=.`:EB9b
1. B7/CD28 v,,
.2UR4
t}
6QU
2. Th1 subset nM#/uuRl|
:O)\+s-
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© @-zL"%%dw'
Mj!\EUn
4. antibody affinity maturation Y2$wL9">
S,0h
&A9
5. AP-1 W2>VgMR [
b,h@.s
6. single chain variable fragment£¨ScFv£© (sDZ&R
@3*S:;x
7. NK cell receptor {3Y
R_^>?
8f`r!/j
8. Zinkernagel-Doherty phenomenon zy'e|92aO
+,c]FAx4
9. Ig fold Dbl3ef
"50c<sZSB
10. CD40/CD40L zu_bno!
GHWt3K:*w
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© um,G^R
7?@ -|{
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ &v)/mc7D
:lU#Dm]
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ =|LB,REN
`c)[aP{vN
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ Xk] uXx:TN
+v+Dkyf:V
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ VX:Kq<XwQ
>PYc57S1c
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ lJ
Jn@A
J?Bj=b
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ H0\', X
CH$K_\
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ 7Y.mp9,
1\aV4T
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ]T=o >%
zeshM8=
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© nxJx
8d"
~^/BAc
1.Co-stimulators (or co-stimulating molecules) GdM|?u&s"
*P\OP'o_
2.NK-kB *+%$OH,
*7{{z%5Pu
3.Immunoglobulin superfamily rRXF@
O[8wF86R
4.antigen-presenting cell (APC) qzWnl[3
^7Ebg5<
5.death domain p'kB1)~|
S;SI#Vg@
6.CCR and CXCR ~H4Tr[8a
zG7y$\A
7.Lectin (or mitogen) '#Q\p6G&_
^YB3$:@$U
8.Clusters of differentiation, CD) [33=+Ca
Z*Fn2I4
9.B7 family CN6b982&
L2%npps
10.Cytotoxic T lymphocyte, CTL) m[%P3
!]MGIh#u
11.IL-15 and IL-15 receptor (IL-15R) t;
@T~%
7Q|v5@;pU
12.MHC restriction dW
%;Z
Nkx W*w%}l
13.Affinity-chromatography D.YT u$T
rW2l+:@c
14.Cyctosprin A, CsA 960rbxKy3
Gu%}B@ 4^
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) vl5r~F
`7_s@4:
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Bz6Zy)&sAL
^oZD44$
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 nn/_>%Y
74a>}+"
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ SI;SnF'[7
!}Ty
"p`
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ M9wj
};vy
%|3NCyJ*7
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© -;t]e6[
J,^e q@(
ÃâÒßѧרҵ£º <9Pf]
G=
% I;iP|/
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ M-NY&